Our aim is to help hospitals make ICU bedsides quieter by safely moving the alarms outside patient rooms
We want to support the important work the Foundation for Queen Silvia Children’s Hospital does to bring joy into the everyday lives of children and young people who are dealing with various illnesses
FDA 510(k) clearance of Getinge’s Flow-e and Flow-c allows us to complete the portfolio of Flow anesthesia machines and offers innovative solutions with personalized anesthesia for high aquity patients in the large and expansive US marketplace.
To help health care providers restart their surgical activity, we looked at how we can utilize our miles of data and knowledge on surgery planning. We now offer a solution that is scalable, easy to deploy, and that offers quick results for staff and patients
During this year’s second quarter, we report a continued strong order intake and net sales of advanced ICU ventilators and ECMO therapy products for hospitals and Sterile Transfer products for the pharmaceutical industry
We are happy to be able to help clinicians in their endeavor to save lives by adding an additional ventilator to our product offering in the US market
With Maquet Moduevo Bridge we are going horizontal. It’s ideal for rooms with low ceilings and can handle large units since they can be placed next to each other to avoid losing space
Patient safety starts in the CSSD, as it is crucial for any hospital that sterile instruments are received by the end user in a safe and timeous manner. With our new indicators, it takes only 20 minutes to ensure a crucial element of patient safety in steam and hydrogen peroxide processes.
The project aims at helping health care facilities to reduce the number of health care associated infections that can occur during operations
We have a long history in New Jersey and this investment solidifies Getinge’s strong commitment to New Jersey and supports leadership training and knowledge sharing with our customers
The quarter was dominated by the COVID-19 pandemic and the huge need for advanced ventilators and ECMO therapy at intensive care units around the world. Our leading global positions in these fields contributed to a 47% organic order growth
We continue to ramp up to be able to respond to the increasing demand from our customers. We work closely with our sub-contractors and the ramp up is of course pending availability of supply parts.
“This is very important for us in order to secure continued deliveries of our products into the EU market and into other markets dependent on the CE-mark"
“Our organic sales growth continued in the fourth quarter and it was particularly good to see the strong performance of our three largest markets – the US, China and Germany,” says Mattias Perjos, President & CEO at Getinge. ”We improved the margins and the cash flow both in the quarter and for the full year, and the balance sheet was strengthened.”
“Sustainability is a top priority and something we see as an integral part of Getinge, and we are of course very honored to receive this award. We will continue our work and progress to contribute to a better society”
“Applikon Biotechnology has a strong portfolio of world class bioreactor solutions which will be a positive addition to Getinge’s existing offer towards the biopharma segment, the fastest growing area within Life Science”, says Mattias Perjos, President & CEO Getinge. “This deal further broadens our position within solutions for efficient, safe and contamination-free research and production processes.”
We, at Getinge Group, are committed to partnering in training with the medical community and therefore very pleased about our ongoing partnership with VASCULAR INTERNATIONAL. Both organizations understand the importance of providing the appropriate training and guidance to surgeons early on in their medical careers. These workshops allow not only hands-on experience on training models but also provide the participants with the opportunity to network and build relationships with medical experts moving forward.